This content is in French.
ALL & acute abdomen: the silent alarm?
15 septembre 2025
By Ana Espino | Published on september 15, 2025 | 2 min read
#Leukemia #ALL #PediatricCancer #Microbiome
Acute lymphoblastic leukemia (ALL) is the most common hematologic malignancy in children, accounting for a major share of pediatric cancers. Thanks to therapeutic advances, survival rates have markedly improved over recent decades. However, adverse events linked to intensive treatments—particularly acute abdomen—remain a leading cause of non-relapse morbidity and mortality, threatening the trajectory of cure.
#Leukemia #ALL #PediatricCancer #Microbiome
Acute lymphoblastic leukemia (ALL) is the most common hematologic malignancy in children, accounting for a major share of pediatric cancers. Thanks to therapeutic advances, survival rates have markedly improved over recent decades. However, adverse events linked to intensive treatments—particularly acute abdomen—remain a leading cause of non-relapse morbidity and mortality, threatening the trajectory of cure.
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Gan, W., et al. (2025). A Multicenter Study of Acute Abdomen in Children With Acute Lymphoblastic Leukemia: CCCG-ALL-2015. Cancer medicine, 14(16), e71090
View the source
